Fintel reports that on December 2, 2025, Mizuho maintained coverage of Evolus (NasdaqGM:EOLS) with a Outperform recommendation.
Analyst Price Forecast Suggests 179.18% Upside
As of November 17, 2025, the average one-year price target for Evolus is $19.04/share. The forecasts range from a low of $14.14 to a high of $21.00. The average price target represents an increase of 179.18% from its latest reported closing price of $6.82 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Evolus is 309MM, an increase of 8.00%. The projected annual non-GAAP EPS is 0.55.
What is the Fund Sentiment?
There are 301 funds or institutions reporting positions in Evolus. This is an decrease of 25 owner(s) or 7.67% in the last quarter. Average portfolio weight of all funds dedicated to EOLS is 0.11%, an increase of 40.45%. Total shares owned by institutions decreased in the last three months by 6.53% to 59,651K shares. 
The put/call ratio of EOLS is 0.03, indicating a bullish outlook.
What are Other Shareholders Doing?
Nantahala Capital Management holds 5,727K shares representing 8.84% ownership of the company. In its prior filing, the firm reported owning 4,198K shares , representing an increase of 26.70%. The firm decreased its portfolio allocation in EOLS by 19.40% over the last quarter.
Tang Capital Management holds 5,488K shares representing 8.47% ownership of the company. In its prior filing, the firm reported owning 4,997K shares , representing an increase of 8.94%. The firm decreased its portfolio allocation in EOLS by 44.24% over the last quarter.
Caligan Partners holds 4,139K shares representing 6.39% ownership of the company. In its prior filing, the firm reported owning 3,342K shares , representing an increase of 19.26%. The firm decreased its portfolio allocation in EOLS by 43.75% over the last quarter.
Frazier Life Sciences Management holds 2,631K shares representing 4.06% ownership of the company. In its prior filing, the firm reported owning 2,436K shares , representing an increase of 7.42%. The firm decreased its portfolio allocation in EOLS by 46.04% over the last quarter.
Millennium Management holds 1,859K shares representing 2.87% ownership of the company. In its prior filing, the firm reported owning 1,483K shares , representing an increase of 20.20%. The firm decreased its portfolio allocation in EOLS by 26.16% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
